1. Home
  2. TRS vs RAPP Comparison

TRS vs RAPP Comparison

Compare TRS & RAPP Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo TriMas Corporation

TRS

TriMas Corporation

HOLD

Current Price

$35.10

Market Cap

1.4B

Sector

Industrials

ML Signal

HOLD

RAPP

Rapport Therapeutics Inc.

HOLD

Current Price

$26.57

Market Cap

1.2B

Sector

N/A

ML Signal

HOLD

Company Overview

Basic Information
Metric
TRS
RAPP
Founded
1986
2022
Country
United States
United States
Employees
N/A
N/A
Industry
Industrial Specialties
Sector
Industrials
Exchange
Nasdaq
Nasdaq
Market Cap
1.4B
1.2B
IPO Year
2007
2024

Fundamental Metrics

Financial Performance
Metric
TRS
RAPP
Price
$35.10
$26.57
Analyst Decision
Strong Buy
Strong Buy
Analyst Count
2
6
Target Price
$41.50
$47.00
AVG Volume (30 Days)
410.5K
351.4K
Earning Date
02-26-2026
03-10-2026
Dividend Yield
0.46%
N/A
EPS Growth
68.70
N/A
EPS
1.08
N/A
Revenue
$1,013,740,000.00
N/A
Revenue This Year
$1.41
N/A
Revenue Next Year
N/A
N/A
P/E Ratio
$32.33
N/A
Revenue Growth
11.83
N/A
52 Week Low
$19.33
$6.43
52 Week High
$40.34
$42.27

Technical Indicators

Market Signals
Indicator
TRS
RAPP
Relative Strength Index (RSI) 53.75 45.59
Support Level $33.80 $25.32
Resistance Level $35.44 $28.59
Average True Range (ATR) 0.87 1.44
MACD 0.03 0.05
Stochastic Oscillator 77.72 41.59

Price Performance

Historical Comparison
TRS
RAPP

About TRS TriMas Corporation

TriMas Corp designs, develops and manufactures a diverse set of products primarily for the consumer products, aerospace & defense, and industrial markets . The company operates through three segments namely: The packaging segment manufactures and distributes closure and dispensing systems. The aerospace segment supplies blind bolts, fasteners, rivets, and other products for the aerospace industry. The specialty product segment manufactures and distributes steel cylinders, wellhead engines, compression systems, industrial sealing, and fasteners.

About RAPP Rapport Therapeutics Inc.

Rapport Therapeutics Inc is a clinical-stage biopharmaceutical company focused on discovery and development of transformational small-molecule medicines for patients suffering from central nervous system disorders. Its foundational science has elucidated the complexities of neuronal receptor biology and enables the company to map and target certain neuronal receptor complexes. Neuronal receptors are complex assemblies of proteins, comprising receptor principal subunits and their receptor-associated proteins (RAPs), the latter of which play crucial roles in regulating receptor expression and function.

Share on Social Networks: